Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer

[1]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[2]  Jing Lv,et al.  Paeonol inhibits human lung cancer cell viability and metastasis in vitro via miR‐126‐5p/ZEB2 axis , 2021, Drug development research.

[3]  Gefei Wang,et al.  Could Jinfukang alleviate the chemotherapy-related adverse effects in non-small cell lung cancer patients? , 2021, Medicine.

[4]  X. Qin,et al.  Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model , 2021, Oxidative medicine and cellular longevity.

[5]  Yuzhu Cao,et al.  Paeonol Suppresses Proliferation and Motility of Non-Small-Cell Lung Cancer Cells by Disrupting STAT3/NF-κB Signaling , 2020, Frontiers in Pharmacology.

[6]  H. Kuang,et al.  Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer , 2020, Chinese medical journal.

[7]  Li Gao,et al.  Uncovering the Complexity Mechanism of Different Formulas Treatment for Rheumatoid Arthritis Based on a Novel Network Pharmacology Model , 2020, Frontiers in Pharmacology.

[8]  A. Tykhomyrov,et al.  The Effect of TIGAR Knockdown on Apoptotic and Epithelial‐Mesenchymal Markers Expression in Doxorubicin‐Resistant Non‐Small Cell Lung Cancer A549 Cell Lines , 2020, Chemistry & biodiversity.

[9]  J. Riess,et al.  Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations , 2020, Current Treatment Options in Oncology.

[10]  Y. Miyagi,et al.  Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next‐generation sequencing technique , 2020, Thoracic cancer.

[11]  S. Yeung,et al.  Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. , 2020, Lung cancer.

[12]  Wenxiao Yang,et al.  A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells , 2020, Frontiers in Pharmacology.

[13]  E. Pamuła,et al.  Stimuli-sensitive fatty acid-based microparticles for the treatment of lung cancer. , 2020, Materials science & engineering. C, Materials for biological applications.

[14]  M. Talkhabi,et al.  Comprehensive transcriptomic analysis identifies novel regulators of lung adenocarcinoma , 2020, Journal of Cell Communication and Signaling.

[15]  M. Cheng,et al.  Silencing of S-phase kinase-associated protein 2 enhances radiosensitivity of esophageal cancer cells through inhibition of PI3K/AKT signaling pathway. , 2020, Genomics.

[16]  Zitong Zhao,et al.  奥希替尼在非小细胞肺癌靶向治疗中的获得性耐药机制 , 2020, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[17]  Manisha Ray,et al.  Lauric Acid Modulates Cancer Associated microRNA Expression and Inhibits the Growth of the Cancer Cell. , 2020, Anti-cancer agents in medicinal chemistry.

[18]  O. Lavrik,et al.  Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy , 2019, International journal of molecular sciences.

[19]  R. Irizarry.  ggplot2 , 2019, Introduction to Data Science.

[20]  F. Sanz,et al.  The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..

[21]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[22]  Jagan Sundaram,et al.  Protective effect of vanillic acid against benzo(a)pyrene induced lung cancer in Swiss albino mice , 2019, Journal of biochemical and molecular toxicology.

[23]  Z. Zeng,et al.  Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT , 2019, Cancer management and research.

[24]  Jih-Hsiang Lee,et al.  Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations , 2019, International journal of cancer.

[25]  M. Xue,et al.  Scopoletin exerts anticancer effects on human cervical cancer cell lines by triggering apoptosis, cell cycle arrest, inhibition of cell invasion and PI3K/AKT signalling pathway. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[26]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[27]  Liang Sun,et al.  SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping , 2018, Nucleic Acids Res..

[28]  Wei Zhang,et al.  ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..

[29]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[30]  Rafal Dziadziuszko,et al.  Alectinib versus Crizotinib in Untreated ALK‐Positive Non–Small‐Cell Lung Cancer , 2017, The New England journal of medicine.

[31]  Jun Chen,et al.  Analysis of the effect of rutin on GSK-3β and TNF-α expression in lung cancer , 2017, Experimental and therapeutic medicine.

[32]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[33]  Jie Song,et al.  Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[34]  Maninder Singh Setia,et al.  Methodology Series Module 5: Sampling Strategies , 2016, Indian journal of dermatology.

[35]  A. Bishayee,et al.  Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update , 2016, Nutrients.

[36]  Lei Yang,et al.  Vitamin E succinate induces apoptosis via the PI3K/AKT signaling pathways in EC109 esophageal cancer cells , 2016, Molecular medicine reports.

[37]  H. Ji,et al.  Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors , 2016, Clinical Cancer Research.

[38]  Tudor I. Oprea,et al.  BDDCS, the Rule of 5 and drugability. , 2016, Advanced drug delivery reviews.

[39]  Chao Li,et al.  CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. , 2015, World journal of gastroenterology.

[40]  Aurélien Grosdidier,et al.  SwissTargetPrediction: a web server for target prediction of bioactive small molecules , 2014, Nucleic Acids Res..

[41]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[42]  Rafael Rosell,et al.  Genetics and biomarkers in personalisation of lung cancer treatment , 2013, The Lancet.

[43]  Monica Campillos,et al.  HitPick: a web server for hit identification and target prediction of chemical screenings , 2013, Bioinform..

[44]  Wei-Chiao Chang,et al.  Molecular Sciences Protective Effect of Caffeic Acid on Paclitaxel Induced Anti-proliferation and Apoptosis of Lung Cancer Cells Involves Nf-κb Pathway , 2022 .

[45]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[46]  J. Kirkland.  Niacin requirements for genomic stability. , 2012, Mutation research.

[47]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[48]  Zhen-ye Xu,et al.  Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy , 2011, Journal of Cancer Research and Clinical Oncology.

[49]  Gang Cheng,et al.  贝伐珠单抗治疗非小细胞肺癌的相关不良反应及处理原则 , 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[50]  Hsi-Chin Wu,et al.  Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. , 2009, Journal of agricultural and food chemistry.

[51]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[52]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[53]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[54]  Wencai Zhang,et al.  Shashen maidong decoction: the effect of TNF-α and IL-6 on lung cancer cachexia based on cancer toxicity theory. , 2021, American journal of translational research.

[55]  Jiansong Fang,et al.  Anticancer activity of polysaccharide from Glehnia littoralis on human lung cancer cell line A549. , 2018, International journal of biological macromolecules.

[56]  Li Shousha.  Clinical Study of Shashenmaidong Decoction in the Treatment of Radiation Pneumonitis , 2015 .

[57]  Lin Huan,et al.  Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer , 2010 .

[58]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[59]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..